NCT07936669
Vaginal Flora Modulation With Lactobacillus and Estriol in Threatened Preterm Labor
StatusCompleted
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Change in Vaginal pH From Baseline to Day 14
Timeframe: Baseline (Day 0) to Day 14
Arms and interventions
6-Day Gynoflor GroupActive comparator
Participants receive one Gynoflor® vaginal tablet once daily for 6 consecutive days. Each vaginal tablet contains Lactobacillus acidophilus KS400 (100 × 10⁶ CFU) and estriol 0.03 mg.
12-Day Gynoflor GroupExperimental
Participants receive one Gynoflor® vaginal tablet once daily for 12 consecutive days. Each vaginal tablet contains Lactobacillus acidophilus KS400 (100 × 10⁶ CFU) and estriol 0.03 mg.
Drugs: Lactobacillus acidophilus and estriol
Sites
1 site in 1 country
- Queen Savang Vadhana Memorial HospitalChon Buri, Thailand